U.S. Markets closed

KORU Medical Systems to Ring Nasdaq Closing Bell on February 12, 2020

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ:KRMD) ("KORU Medical" or the "Company") today announced that Don Pettigrew, President & CEO, will ring the Nasdaq Closing Bell on Wednesday, February 12, 2020 at 4:00 pm ET.

"We are honored to ring the closing bell in celebration of our recent uplisting to Nasdaq, our corporate re-branding to KORU Medical Systems, and our position as a market leader of innovative and easy-to-use specialty infusion devices," said Mr. Pettigrew. "We appreciate the support of our customers, industry partners, shareholders, employees, and board members, and remain focused on providing new life and new beginnings to patients around the world who use KORU Medical’s integrated Freedom Syringe Infusion System. We continue to look forward to our future with confidence."

About KORU Medical Systems
KORU Medical Systems develops, manufactures and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.

Forward-Looking Statements
The statements contained herein include prospects, statements of future expectations and other forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are based on management's current views and assumptions and involve known and unknown risks and uncertainties. Actual results, performance or events may differ materially from those expressed or implied in such forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: introduction of competitive products; availability of insurance reimbursement; changes in U.S. Food and Drug Administration regulations; changes to health care policies; success of our research and development efforts; our ability to raise capital if or when needed; acceptance of and demand for new and existing products; expanded market acceptance of the FREEDOM Syringe Infusion System; our ability to obtain required governmental approvals; success in enforcing and obtaining patents; continued performance by principal suppliers; continued customer preference to work through distributors; continued service of key personnel and attracting and maintaining new personnel; the costs, duration and ultimate outcome of litigation; and general economic and business conditions. These and other risks are discussed in the Company’s filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K, which filings are available from the SEC and the Company’s website. The Company undertakes no obligation to update any forward-looking statements.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200210005690/en/

Contacts

The Equity Group Inc.
Devin Sullivan
Senior Vice President
212-836-9608
dsullivan@equityny.com

Kalle Ahl, CFA
Vice President
212-836-9614
kahl@equityny.com

  • Business
    Barrons.com

    The Dow Is Down 1000 Points. Here’s What History Says Happens Next.

    From a technical perspective, the S&P 500 should find support near its Jan. 31 low of 3225.52, according to Macro Risk Advisors' John Kolovos. That's right about where the S&P 500, at 3,228.99, is now, and if that breaks a full-blown correction is likely in play. This is the type of distributive selling that will require a good and proper reset in price, sentiment and or time on a break,” he writes.

  • The Dow tumbled more than 1,000 points and marked its third-worst point drop in history — here’s how the stock market tends to perform after big drops
    Business
    MarketWatch

    The Dow tumbled more than 1,000 points and marked its third-worst point drop in history — here’s how the stock market tends to perform after big drops

    The day's decline marks the third-biggest daily point drop for the Dow Jones Industrial Average (DJIA) in its 124-year history. To be sure, such point drops are less meaningful because the Dow has been trading at lofty levels. For example, the Dow's 1987 crash was a 508-point decline but that fall represented a 23% plunge back then.

  • Business
    NerdWallet

    How the IRS Knows If You Cheat on Your Taxes

    Those forms, called information returns, typically are records of certain payments you received or made during the tax year that you usually need to report on your tax return. Some of the most common information returns are W-2s, which report wages earned from a job, and 1099s, which report money received for things such as freelance work, dividends or interest. But other money moves you make could put information returns in the IRS' mailbox, too, says Ignatius Jackson, a certified public accountant in Phoenix.

  • 'Flat earther' dies in rocket crash
    U.S.
    Associated Press Videos

    'Flat earther' dies in rocket crash

    A California man who said he wanted to fly to the edge of outer space to see if the world is round has died after his home-built rocket blasted off into the desert sky and plunged back to earth. Feb.

  • Buffett is bullish on stocks but says the market can drop 50% — is he wrong?
    Business
    MarketWatch

    Buffett is bullish on stocks but says the market can drop 50% — is he wrong?

    Stock market investors are watching the coronavirus spreading far beyond China. It is no longer mostly in Asia. Italy has reported six coronavirus deaths and an accelerating number of cases.

  • Palo Alto Earnings Guidance Falls Short, Cybersecurity Stock Plunges
    Business
    Investor's Business Daily

    Palo Alto Earnings Guidance Falls Short, Cybersecurity Stock Plunges

    Palo Alto Networks earnings for its fiscal second quarter fell from the year-earlier period but topped views as revenue fell far short of analyst estimates. The Palo Alto earnings news and weak guidance sent shares in the cybersecurity firm tumbling in extended trading Monday. Santa Clara, Calif.

  • Here are the worst-performing stocks Monday as investors panic over the coronavirus
    Business
    MarketWatch

    Here are the worst-performing stocks Monday as investors panic over the coronavirus

    a href="https://www.marketwatch.com/story/here-are-the-worst-performing-stocks-monday-as-investors-panic-over-the-coronavirus-2020-02-24? siteid=yhoof2" (UNH) -7.8% -5.5% -9.4% 18.0% American Express Co.

  • UnitedHealth stock plunges toward worst day in nearly 9 years as Sanders’ Nevada win stokes investor fear
    Business
    MarketWatch

    UnitedHealth stock plunges toward worst day in nearly 9 years as Sanders’ Nevada win stokes investor fear

    Shares of UnitedHealth Group Inc. plunged toward their worst day in nearly 9 years Monday, as the narrative around a potential Bernie Sanders nomination may have swung to negative from positive following the senator's surprisingly big win in Nevada. Other health insurer stocks also took deeper dives than the broader stock market in afternoon trading. Shares of Centene Corp. (CNC) , which provides programs and services to government-sponsored health-care programs, plunged 10.2% to pace the 492 of 505 stocks on the S&P 500 index (SPX)  that were losing ground.

  • Gilead Surges After WHO Comments on Virus Drug Testing
    Business
    Bloomberg

    Gilead Surges After WHO Comments on Virus Drug Testing

    Gilead's compound, remdesivir, has been rushed into a clinical trial in China, where the illness has infected tens of thousands of people. Remdesivir is the “one drug right now that we think may have efficacy,” Bruce Aylward, an assistant director-general at the World Health Organization, said at a briefing in Beijing. Gilead shares rose 4.6% to $72.90 on Monday, the highest closing level since October 2018.

  • Markets ‘powered through’ SARS, but the coronavirus outbreak is different, Cowen says — and here’s why
    Business
    MarketWatch

    Markets ‘powered through’ SARS, but the coronavirus outbreak is different, Cowen says — and here’s why

    U.S. stocks may not be able to “power through” the coronavirus as they did with the SARS outbreak and the travel industry will take longer to recover, analysts at broker Cowen are warning. Global stocks tumbled on Monday as the spread of the coronavirus outside China intensified, with Italy and South Korea reporting a spike in new cases. The Dow Jones Industrial Average (DJIA) lost 760 points shortly after the open, and is now 1% down year-to-date, while the S&P (SPX) fell 2.5% in early trading and is 0.7% up so far in 2020.

  • Business
    Barrons.com

    Stock Trading Will Be Halted if the Market Falls Too Much. It Isn’t Even Close.

    Level One Breach A 7% decline in the S&P 500 from the prior day's close would trigger a so-called level one breach, where trading is halted for 15 minutes. That level on Monday is 3104.11. The S&P 500 closed at 3337.75 on Friday).

  • Why Fidelity 401(k) Millionaires Average $1.46 Mil Balances
    Business
    Investor's Business Daily

    Why Fidelity 401(k) Millionaires Average $1.46 Mil Balances

    The number of people with $1 million or more in 401(k) accounts in plans run by Fidelity Investments rose to a record 233,000. And the number of IRA millionaires — savers with balances of $1 million or more in accounts held at Fidelity — hit 208,000, also a record. Fidelity 401(k) Millionaire Traits In addition, Fidelity disclosed several of its 401(k) millionaires' traits: The average 401(k) balance for its millionaires reached $1,462,000.

  • Warren Buffett on coronavirus fears: I won’t be selling stocks
    Business
    Yahoo Finance Video

    Warren Buffett on coronavirus fears: I won’t be selling stocks

    Berkshire Hathaway CEO Warren Buffett isn't panicking about the impact of the coronavirus on markets in the long-term. Yahoo Finance's Seana Smith and CFRA research analyst Cathy Seifert discuss his remarks, along with Berkshire Hathaway's earnings results.

  • Tesla stock hit hard by coronavirus fears and broad market selloff
    Business
    MarketWatch

    Tesla stock hit hard by coronavirus fears and broad market selloff

    Tesla Inc. stock fell more than 7% Monday amid a broad equity selloff triggered by fears the spread of the COVID-19 virus might tip the world into economic chaos. Tesla (TSLA) shares traded at their lowest level in 10 days and are on pace for their largest one-day percentage decline since Feb. 5, when the stock lost 17.2% following a couple of ratings downgrades. The COVID-19 outbreak in China has been called “a clear headwind” for Tesla, which has pinned a lot of its expansion plans on the Chinese market and the performance of its Shanghai factory.

  • Investors unable to access brokerage accounts as stocks fall — what you should know for your retirement accounts
    Business
    MarketWatch

    Investors unable to access brokerage accounts as stocks fall — what you should know for your retirement accounts

    Investors are advised not to change their investment portfolios when the market is volatile — some were forced to take that advice when they couldn't access their accounts Monday morning. Some Fidelity Investment users tweeted Monday morning that at the start of the trading day, they couldn't log in to their accounts, or when they did, they saw a $0 balance. This comes less than a week after Fidelity customers were unable to access their accounts, or came across with no balance for their 401(k) and other investment portfolios.

  • Business
    Benzinga

    Warren Buffett On Monday's Market Plunge: 'That's Good For Us'

    Warren Buffett said in a CNBC interview Monday he prefers buying stocks at a cheaper price so Monday's sell-off is something "that's good for us." Buffett's annual chat with CNBC's Becky Quick coincided with a large sell-off in U.S. stocks as confirmed coronavirus cases are popping up in large numbers worldwide. But Buffett will be "buying on balance" and he "certainly won't" be selling any shares.

  • U.S. Supreme Court turns away religious bias claim against Walgreens
    U.S.
    Reuters

    U.S. Supreme Court turns away religious bias claim against Walgreens

    The U.S. Supreme Court on Monday handed a victory to Walgreens, turning away an appeal by a fired former Florida employee of the pharmacy chain who asked not to work on Saturdays for religious reasons as a member of the Seventh-day Adventist Church. The justices declined to review a lower court ruling in Darrell Patterson's religious discrimination lawsuit that concluded that his demand to never work on Saturday, observed as the Sabbath by Seventh-day Adventists, placed an undue hardship on Walgreens. Patterson, who had trained customer service representatives at a Walgreens call center in Orlando, was fired in 2011 after failing to show up for work on a Saturday for an urgent training session.

  • One of the market’s hottest stocks just bounced into the green to buck selloff
    Business
    MarketWatch

    One of the market’s hottest stocks just bounced into the green to buck selloff

    Virgin Galactic shares, which have been on a ridiculous tear lately, started Monday's session just like most stocks did — deep in the red. Yes, Richard Branson's Virgin Galactic (SPCE) saw its stock take a double-digit hit early, following the Dow Jones Industrial Average (DJIA) and the S&P 500 (SPX)into negative territory. But while the indexes failed to shake coronavirus fears throughout the day, Virgin Galactic, as you can see, caught a swarm of dip-buyers, who pushed the stock up more than 4% on heavy volume as the trading day wound down.

  • Duke Energy, Williams Cos. and partners end the $1B Constitution Pipeline project
    Business
    American City Business Journals

    Duke Energy, Williams Cos. and partners end the $1B Constitution Pipeline project

    Duke Energy Corp. confirms that the four partners in the Constitution Pipeline have agreed to abandon the 124-mile project designed to carry natural gas from shale fields in Pennsylvania to New York and New England. “Although Constitution did receive positive outcomes in recent court proceedings and permit applications, the economics associated with this greenfield project have since changed in such a way that they no longer justify investment,” says Duke spokeswoman Tammie McGee. The delays and legal challenges have since driven up the costs by close to 40%.

  • Warren Buffett says ‘don’t buy or sell’ on the headlines as coronavirus sends stocks plunging
    Business
    MarketWatch

    Warren Buffett says ‘don’t buy or sell’ on the headlines as coronavirus sends stocks plunging

    Global stocks are plunging on Monday after the number of virus cases outside China surged over the weekend, particularly in Italy, South Korea and Iran. European stocks also plummeted, with Italy's FTSE MIB (IT:I945) leading the descent, falling 5.9%. “The real question is: 'Has the 10-year or 20-year outlook for American businesses changed in the last 24 or 48 hours?'” the billionaire investor said on CNBC.

  • Politics
    Bloomberg

    Buttigieg Calls for SALT Cap Removal Ahead of California Primary

    Buttigieg updated his tax plan Monday, adding a plank that would remove the $10,000 limit on so-called SALT deductions for those earning up to $400,000, partially reversing a provision in President Donald Trump's tax law that capped those write-offs, which were previously unlimited. The proposal is likely to play well in high-tax states such as California, New York and New Jersey, Democratic strongholds where local leaders have said the cap hurts residents whose incomes and property values tend to be higher.

  • India To Buy $3 Billion In U.S. Weapons But This Key Deal Awaits
    Politics
    Investor's Business Daily

    India To Buy $3 Billion In U.S. Weapons But This Key Deal Awaits

    President Donald Trump said India will sign $3 billion in military deals with the U.S. Tuesday, while Boeing and Lockheed Martin remain in a dogfight to win a massive fighter jet deal. Defense stocks dropped. Earlier this month, the State Department approved the sale of a Raytheon Integrated Air Defense Weapon System, which includes radars and missiles, to India as part of a $1.87 billion package.

  • United Therapeutics gets good news — and stock boost — from drug candidate
    Business
    American City Business Journals

    United Therapeutics gets good news — and stock boost — from drug candidate

    It's a good day for United Therapeutics Corp. The Silver Spring biotech announced Monday its pulmonary arterial hypertension treatment, Tyvaso, essentially passed its clinical tests among patients with interstitial lung disease — a bright spot after the company faced back-to-back failed late-stage trials in both a cancer therapy and a different PAH product in the last year-plus. The phase 3 trial, per a preliminary analysis, demonstrated that 16 weeks of treatment with Tyvaso was effective in increasing the distance, by 21 meters, that patients could walk in six minutes when compared with a placebo. The news sent the company's stock rising nearly 7% in Monday afternoon trading to $114.41 per share by about 1:45 p.m. Tyvaso could fill a major unmet medical need — there are currently no approved therapies for the roughly 30,000 PAH patients with interstitial lung disease, which causes scarring of the lungs and hinders breathing.

  • The 10-year Treasury yield is sliding toward its all-time low — here’s why
    Business
    MarketWatch

    The 10-year Treasury yield is sliding toward its all-time low — here’s why

    As U.S. stocks headed for the biggest one-day selloff in more than a year, investors took shelter in the deepest, most liquid haven asset in the world — U.S. Treasurys. Fears the COVID-19 outbreak could delay a global economic recovery for longer than expected has drawn investors to government bonds. The 10-year Treasury note yield (BX:TMUBMUSD10Y)  tumbled more than 10 basis points to trade at 1.377% on Monday, a few basis points away from its record low of 1.32% set in June 2016, Tradeweb data show.

  • Why This Is The Only Marijuana Stock A Top Pot Analyst Still Rates As A Buy
    Business
    Investor's Business Daily

    Why This Is The Only Marijuana Stock A Top Pot Analyst Still Rates As A Buy

    Marijuana stocks fell Monday as Cowen downgraded Aurora Cannabis stock and Tilray, but kept Canopy Growth stock as its only "outperform" rating, amid ongoing supply and cash difficulties in Canada's legal recreational rollout and better prospects in the U.S. In a research note on Monday, Cowen analyst Vivien Azer said issues that have hurt the industry — too few stores to sell weed, difficulty bringing illicit-market customers into the legal market — "do not appear to be fading as anticipated." Newer legal products, like edibles and vapes, are "likely not the elixir that the market was hoping for," she said. Factoring those issues together, Cowen also slashed its full-year sales forecast by 32% to 3.5 billion Canadian dollars ($2.63 billion) in legal cannabis sales.